Funding

Efferon

Germany · Biotech · Healthtech · Enterprise software

Develops hemoadsorption therapeutic devices for sepsis and septic shock treatment

Visit efferon.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed€2.5MParticipants not disclosed

Investors

No participants disclosed.

Coverage

May 21, 2026Efferon · Seed

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Sourcesefferon.com ↗